Education
About Us
Working with TipRanks
Follow Us
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 131.16M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 125.88M | $ -383.00K | $ -531.00K | $ -199.00K | $ -155.00K |
| Operating Income | $ -217.27M | $ -206.06M | $ -146.91M | $ -72.74M | $ -13.78M |
| EBITDA | $ -217.27M | $ -206.06M | $ -141.65M | $ -72.56M | $ -43.66M |
| Net Income | $ -95.50M | $ -188.92M | $ -132.18M | $ -70.44M | $ -40.51M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 531.72M | $ 366.35M | $ 342.27M | $ 284.31M | $ 43.73M |
| Total Assets | $ 582.79M | $ 376.05M | $ 349.06M | $ 289.82M | $ 45.66M |
| Total Debt | $ 2.60M | $ 408.00K | $ 813.00K | $ 220.00K | $ 402.00K |
| Net Debt | $ -122.37M | $ -230.38M | $ -84.45M | $ -284.09M | $ -43.33M |
| Total Liabilities | $ 80.04M | $ 29.51M | $ 17.02M | $ 8.67M | $ 94.16M |
| Stockholders' Equity | $ 502.75M | $ 346.54M | $ -269.67M | $ -127.49M | $ -54.20M |
| Cash Flow | |||||
| Free Cash Flow | $ -80.28M | $ -150.08M | $ -109.90M | $ -56.54M | $ -13.58M |
| Operating Cash Flow | $ -78.11M | $ -146.85M | $ -109.87M | $ -48.54M | $ -13.49M |
| Investing Cash Flow | $ -230.99M | $ 128.38M | $ -255.07M | $ -8.00M | $ -92.00K |
| Financing Cash Flow | $ 203.29M | $ 164.00M | $ 165.90M | $ 297.12M | $ 29.98M |